Te rugăm să aștepți; încărcăm datele diagramei imediat
Comunitate AstraZeneca PLC
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 825,07 lei, with a 24-hour trading volume of 1,25B lei. The asset's market cap is 1,27T lei, after moving 1.86% in the last day.
Tokenized AstraZeneca PLC is trading at 456,99 lei, with a tokenized market cap of 258,73M lei and a 24-hour trading volume of 3,28M lei. The tokenized asset has moved 12.66% in the past 24 hours.